四肢软组织和骨源性肉瘤血管手术后的临床和手术效果。

IF 1.9 Q4 ONCOLOGY
Cancer reports Pub Date : 2025-10-08 DOI:10.1002/cnr2.70353
Sebastian Kapahnke, Matthias Bürger, Melanie Rusch, Grischa Hoffmann, Philipp Johannes Pauli, Lars Hummitzsch, Martin Albrecht, Roland Bertolini, Julia Bertolini, Rene Rusch, Rouven Berndt, Christoph Röcken, Daniel Drücke, Katharina Hess
{"title":"四肢软组织和骨源性肉瘤血管手术后的临床和手术效果。","authors":"Sebastian Kapahnke,&nbsp;Matthias Bürger,&nbsp;Melanie Rusch,&nbsp;Grischa Hoffmann,&nbsp;Philipp Johannes Pauli,&nbsp;Lars Hummitzsch,&nbsp;Martin Albrecht,&nbsp;Roland Bertolini,&nbsp;Julia Bertolini,&nbsp;Rene Rusch,&nbsp;Rouven Berndt,&nbsp;Christoph Röcken,&nbsp;Daniel Drücke,&nbsp;Katharina Hess","doi":"10.1002/cnr2.70353","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Soft tissue sarcomas (STS) and osteogenic sarcomas (OGS) of the limbs are rare diseases. Nowadays, most patients with STS or OGS undergo tumor resection and subsequent vascular reconstruction for potential limb preservation.</p>\n </section>\n \n <section>\n \n <h3> Aims</h3>\n \n <p>Due to very limited data on these complex surgical procedures, the aim of this single-center, retrospective study was to evaluate the surgical and oncological outcomes of these patients.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>From 2013 to 2023, demographic, clinical, surgical, and pathological data regarding tumor disease, surgical treatment, and postoperative care of a total of 10 patients with STS and OGS were identified and analyzed. Furthermore, overall survival (OS) and freedom from tumor recurrence (FFT) were retrospectively investigated among all patients.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>The mean age of the patients was 64.4 ± 22.24 years, and six women (60%) and four men (40%) were treated. Overall, 16 major arterial and venous vessels were resected and reconstructed: the lower extremity was affected in nine patients (90%). Autologous veins (<i>n</i> = 12, 75%), polytetrafluoroethylene (PTFE; <i>n</i> = 2, 12.5%), or cryopreserved allografts (<i>n</i> = 2, 12.5%) were mainly used for vascular reconstruction. The follow-up ranged from 7 to 60 months, with a median OS of 48 months and a median FFT of 54 months. Overall, four patients (40%) developed local tumor recurrence at the primary surgical resection site or metastasis. The primary graft patency for all vascular reconstructions was 90% at the median follow-up of 24 months. All revascularized limbs among these patients could be salvaged during the follow-up period.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Treatment of patients with STS or OGS of the limbs and subsequent vascular reconstruction can be performed safely and effectively. The outcomes described in this cohort suggest that an interdisciplinary team, including vascular surgeons and a carefully planned and rigorous clinical approach, might positively influence the postoperative and oncological outcome and limb salvage.</p>\n </section>\n </div>","PeriodicalId":9440,"journal":{"name":"Cancer reports","volume":"8 10","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2025-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12505814/pdf/","citationCount":"0","resultStr":"{\"title\":\"Clinical and Surgical Outcome After Oncovascular Surgery of Soft Tissue and Osteogenic Sarcomas of the Limbs\",\"authors\":\"Sebastian Kapahnke,&nbsp;Matthias Bürger,&nbsp;Melanie Rusch,&nbsp;Grischa Hoffmann,&nbsp;Philipp Johannes Pauli,&nbsp;Lars Hummitzsch,&nbsp;Martin Albrecht,&nbsp;Roland Bertolini,&nbsp;Julia Bertolini,&nbsp;Rene Rusch,&nbsp;Rouven Berndt,&nbsp;Christoph Röcken,&nbsp;Daniel Drücke,&nbsp;Katharina Hess\",\"doi\":\"10.1002/cnr2.70353\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>Soft tissue sarcomas (STS) and osteogenic sarcomas (OGS) of the limbs are rare diseases. Nowadays, most patients with STS or OGS undergo tumor resection and subsequent vascular reconstruction for potential limb preservation.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Aims</h3>\\n \\n <p>Due to very limited data on these complex surgical procedures, the aim of this single-center, retrospective study was to evaluate the surgical and oncological outcomes of these patients.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>From 2013 to 2023, demographic, clinical, surgical, and pathological data regarding tumor disease, surgical treatment, and postoperative care of a total of 10 patients with STS and OGS were identified and analyzed. Furthermore, overall survival (OS) and freedom from tumor recurrence (FFT) were retrospectively investigated among all patients.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>The mean age of the patients was 64.4 ± 22.24 years, and six women (60%) and four men (40%) were treated. Overall, 16 major arterial and venous vessels were resected and reconstructed: the lower extremity was affected in nine patients (90%). Autologous veins (<i>n</i> = 12, 75%), polytetrafluoroethylene (PTFE; <i>n</i> = 2, 12.5%), or cryopreserved allografts (<i>n</i> = 2, 12.5%) were mainly used for vascular reconstruction. The follow-up ranged from 7 to 60 months, with a median OS of 48 months and a median FFT of 54 months. Overall, four patients (40%) developed local tumor recurrence at the primary surgical resection site or metastasis. The primary graft patency for all vascular reconstructions was 90% at the median follow-up of 24 months. All revascularized limbs among these patients could be salvaged during the follow-up period.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>Treatment of patients with STS or OGS of the limbs and subsequent vascular reconstruction can be performed safely and effectively. The outcomes described in this cohort suggest that an interdisciplinary team, including vascular surgeons and a carefully planned and rigorous clinical approach, might positively influence the postoperative and oncological outcome and limb salvage.</p>\\n </section>\\n </div>\",\"PeriodicalId\":9440,\"journal\":{\"name\":\"Cancer reports\",\"volume\":\"8 10\",\"pages\":\"\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2025-10-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12505814/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/cnr2.70353\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer reports","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cnr2.70353","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:四肢软组织肉瘤(STS)和骨源性肉瘤(OGS)是一种罕见的疾病。目前,大多数STS或OGS患者接受肿瘤切除和随后的血管重建,以潜在地保留肢体。目的:由于这些复杂手术的资料非常有限,本单中心回顾性研究的目的是评估这些患者的手术和肿瘤预后。方法:对2013 - 2023年共10例STS和OGS患者的肿瘤疾病、手术治疗和术后护理的人口学、临床、手术和病理资料进行分析。此外,对所有患者的总生存期(OS)和无肿瘤复发(FFT)进行回顾性调查。结果:患者平均年龄64.4±22.24岁,其中女性6例(60%),男性4例(40%)。总的来说,16条主要的动脉和静脉血管被切除并重建:9名患者(90%)的下肢受到影响。血管重建主要采用自体静脉(n = 12, 75%)、聚四氟乙烯(PTFE; n = 2, 12.5%)或冷冻保存同种异体移植物(n = 2, 12.5%)。随访时间为7至60个月,中位OS为48个月,中位FFT为54个月。总体而言,4例患者(40%)在原发手术切除部位出现局部肿瘤复发或转移。在中位随访24个月时,所有血管重建的初级移植物通畅度为90%。在随访期间,所有血运重建的肢体均可恢复。结论:四肢STS或OGS患者的治疗及后续血管重建是安全有效的。本队列中描述的结果表明,一个跨学科的团队,包括血管外科医生和精心计划和严格的临床方法,可能会对术后和肿瘤结果以及肢体保留产生积极影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Clinical and Surgical Outcome After Oncovascular Surgery of Soft Tissue and Osteogenic Sarcomas of the Limbs

Clinical and Surgical Outcome After Oncovascular Surgery of Soft Tissue and Osteogenic Sarcomas of the Limbs

Background

Soft tissue sarcomas (STS) and osteogenic sarcomas (OGS) of the limbs are rare diseases. Nowadays, most patients with STS or OGS undergo tumor resection and subsequent vascular reconstruction for potential limb preservation.

Aims

Due to very limited data on these complex surgical procedures, the aim of this single-center, retrospective study was to evaluate the surgical and oncological outcomes of these patients.

Methods

From 2013 to 2023, demographic, clinical, surgical, and pathological data regarding tumor disease, surgical treatment, and postoperative care of a total of 10 patients with STS and OGS were identified and analyzed. Furthermore, overall survival (OS) and freedom from tumor recurrence (FFT) were retrospectively investigated among all patients.

Results

The mean age of the patients was 64.4 ± 22.24 years, and six women (60%) and four men (40%) were treated. Overall, 16 major arterial and venous vessels were resected and reconstructed: the lower extremity was affected in nine patients (90%). Autologous veins (n = 12, 75%), polytetrafluoroethylene (PTFE; n = 2, 12.5%), or cryopreserved allografts (n = 2, 12.5%) were mainly used for vascular reconstruction. The follow-up ranged from 7 to 60 months, with a median OS of 48 months and a median FFT of 54 months. Overall, four patients (40%) developed local tumor recurrence at the primary surgical resection site or metastasis. The primary graft patency for all vascular reconstructions was 90% at the median follow-up of 24 months. All revascularized limbs among these patients could be salvaged during the follow-up period.

Conclusion

Treatment of patients with STS or OGS of the limbs and subsequent vascular reconstruction can be performed safely and effectively. The outcomes described in this cohort suggest that an interdisciplinary team, including vascular surgeons and a carefully planned and rigorous clinical approach, might positively influence the postoperative and oncological outcome and limb salvage.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Cancer reports
Cancer reports Medicine-Oncology
CiteScore
2.70
自引率
5.90%
发文量
160
审稿时长
17 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信